Detalhe da pesquisa
1.
Streptolysin O Deficiency in Streptococcus pyogenes M1T1 covR/S Mutant Strain Attenuates Virulence in In Vitro and In Vivo Infection Models.
mBio
; 14(1): e0348822, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36744883
2.
A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils.
Nat Commun
; 14(1): 5963, 2023 09 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37749129
3.
Combinatorial liposomal peptide vaccine induces IgA and confers protection against influenza virus and bacterial super-infection.
Clin Transl Immunology
; 10(9): e1337, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34527244
4.
Cellular interactions of covR/S mutant group A Streptococci.
Microbes Infect
; 20(9-10): 531-535, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29287985
5.
Skin infection boosts memory B-cells specific for a cryptic vaccine epitope of group A streptococcus and broadens the immune response to enhance vaccine efficacy.
NPJ Vaccines
; 3: 15, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29736269
6.
Novel platform technology for modular mucosal vaccine that protects against streptococcus.
Sci Rep
; 6: 39274, 2016 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27976706